Document Detail


Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis.
MedLine Citation:
PMID:  23137049     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objectives. Recent epidemiological studies suggest that metformin treatment may reduce the risks of cancer and overall cancer mortality among patients with diabetes mellitus (DM). However, data on hepatocellular carcinoma (HCC) are very limited and inconsistent. This meta-analysis was designed to pool data currently available to determine the association between metformin use and HCC among diabetic patients. Methods. The Medline and Embase databases were searched to identify the relevant studies between January 1966 and December 2011. The overall analysis was derived using a random-effects meta-analysis model (DerSimonian and Laird method). Subgroup analysis was performed to explore the source of heterogeneity and validate the results from overall analysis. The Newcastle-Ottawa Quality assessment scales were adopted for quality assessment; Begg's funnel plot and Egger's regression asymmetry test were used to detect the publication bias. Results. A total of seven studies were identified, including three cohort studies and four case-control studies. Based on the available data, the overall prevalence of HCC was 3.40% (562/16,549) in DM patients. The overall analysis showed a significantly reduced risk of HCC in metformin users versus nonusers in diabetic patients (relative risk (RR) 0.24, 95% confidence interval (CI) 0.13-0.46, p < 0.001). Fifteen subgroup analyses were performed, and most of them (12/15 = 80%) provided supporting evidence for the results of overall analysis. Begg's (Z = -0.15, p = 0.8819) and Egger's test (t = -0.79, p = 0.468) showed no significant risk of having a publication bias. Conclusion. Metformin treatment was associated with reduced risk of HCC in diabetic patients. To clarify this relationship, more high-quality studies are required.
Authors:
Hui Zhang; Chun Gao; Long Fang; Hong-Chuan Zhao; Shu-Kun Yao
Related Documents :
8477879 - Human insulin receptor substrate-1 gene (irs1): chromosomal localization to 2q35-q36.1 ...
24775899 - Coronary risk assessment in subjects with type 2 diabetes mellitus. general population-...
23796159 - Red cell distribution width and hypertensive response to exercise in patients with type...
19557019 - High glucose attenuates insulin-induced vegf expression in bovine retinal microvascular...
9363209 - Advances in the understanding of diabetic embryopathy: signal transduction.
18832759 - Regulation of caspase-3 activity by insulin in skeletal muscle cells involves both pi3-...
22068019 - Evaluation of serum level of tumor necrosis factor receptor ii in hepatitis c virus (ge...
2876059 - Hyperglycemia preserves brain mitochondrial respiration during anoxia.
23016899 - Lipid-lowering therapy in the diabetic foot: seeing the whole iceberg and not just the ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Scandinavian journal of gastroenterology     Volume:  -     ISSN:  1502-7708     ISO Abbreviation:  Scand. J. Gastroenterol.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0060105     Medline TA:  Scand J Gastroenterol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Gastroenterology, China-Japan Friendship Hospital, Peking University Health Science Center , Beijing , P. R. China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  1H and 13C NMR Assignments for the Cyanine Dyes SYBR® Safe and Thiazole Orange.
Next Document:  Point Accuracy of Interstitial Continuous Glucose Monitoring During Exercise in Type 1 Diabetes.